Community Health Systems (NYSE:CYH) Issues FY 2026 Earnings Guidance

Community Health Systems (NYSE:CYH) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of -0.600-0.000 for the period, compared to the consensus estimate of -0.420. The company issued revenue guidance of $11.6 billion-$12.0 billion, compared to the consensus revenue estimate of $12.8 billion.

Community Health Systems Stock Performance

Community Health Systems stock opened at $3.53 on Friday. The company has a market capitalization of $488.28 million, a PE ratio of 0.94 and a beta of 2.10. Community Health Systems has a fifty-two week low of $2.24 and a fifty-two week high of $4.47. The firm has a 50 day moving average price of $3.24 and a 200 day moving average price of $3.18.

Community Health Systems (NYSE:CYH) last released its quarterly earnings results on Wednesday, February 18th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of ($0.20) by $1.00. Community Health Systems had a negative return on equity of 10.80% and a net margin of 4.08%.The business had revenue of $3.11 billion during the quarter, compared to analyst estimates of $3.14 billion. During the same period last year, the business posted ($0.42) earnings per share. The company’s quarterly revenue was down 4.9% on a year-over-year basis. Community Health Systems has set its FY 2026 guidance at -0.600-0.000 EPS. As a group, equities research analysts forecast that Community Health Systems will post -0.29 earnings per share for the current year.

Analysts Set New Price Targets

CYH has been the subject of a number of research reports. Wall Street Zen cut shares of Community Health Systems from a “buy” rating to a “hold” rating in a report on Sunday, November 2nd. Truist Financial set a $4.50 price objective on Community Health Systems in a research report on Monday, January 5th. Wells Fargo & Company decreased their target price on Community Health Systems from $3.00 to $2.00 and set an “underweight” rating for the company in a report on Wednesday, January 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Community Health Systems in a research note on Monday, December 29th. Finally, UBS Group lifted their price objective on Community Health Systems from $3.20 to $3.60 and gave the company a “neutral” rating in a research note on Monday, October 27th. One analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Community Health Systems currently has an average rating of “Hold” and an average target price of $3.60.

Institutional Investors Weigh In On Community Health Systems

A number of institutional investors have recently added to or reduced their stakes in CYH. Oxford Asset Management LLP purchased a new stake in Community Health Systems during the fourth quarter worth $45,000. Millennium Management LLC purchased a new position in Community Health Systems during the 4th quarter valued at about $263,000. Engineers Gate Manager LP acquired a new position in Community Health Systems during the fourth quarter worth about $204,000. Balyasny Asset Management L.P. acquired a new stake in shares of Community Health Systems in the fourth quarter valued at approximately $692,000. Finally, Aristeia Capital L.L.C. purchased a new position in shares of Community Health Systems during the 4th quarter worth approximately $319,000. Hedge funds and other institutional investors own 84.99% of the company’s stock.

Community Health Systems Company Profile

Community Health Systems, Inc (NYSE: CYH) is one of the largest publicly traded hospital operators in the United States. Headquartered in Franklin, Tennessee, the company owns, leases and manages general acute care hospitals and outpatient facilities, primarily in non-urban and mid-market communities. CHS is focused on delivering locally accessible healthcare services through its network of affiliated hospitals, clinics and post-acute providers.

The company’s core offerings include inpatient medical and surgical care, emergency services, critical care, diagnostic imaging and laboratory testing.